Literature DB >> 385303

Chronic effects of [D-Trp6,Pro9-NEt]luteinizing hormone-releasing factor on reproductive processes in the male rat.

C Rivier, J Rivier, W Vale.   

Abstract

Chronic administration of a potent LRF agonist, [D-Trp6,Pro9-NEt]LFR (A), to intact adult male rats induced a dose-related decrease in testicular and accessory organ weights, diminished production of testosterone (T), and disrupted tubular morphology, indicative of suppression of spermatogenesis. Transient elevations of plasma progesterone levels and a marked reduction of PRL secretion were also observed in A-treated rats. The effects of A on testicular weights, T levels, and seminiferous tubule morphology were already apparent 3 days after the first injection. Administration of A was equally effective when administered daily or at 1- to 4-day intervals in lowering steroid levels and testicular weights. After a 1-week daily exposure to A, seminal vesicles and prostate weights as well as T levels returned to control values within 1--2 weeks. Testicular weights, however, were still depressed 4 weeks after cessation of treatment, and germinal epithelium was disrupted in 30--40% of the tubules. Measurement of T and LH plasma levels after each daily injection of A indicated a blunting of succeeding A-induced elevations of LH and T, which lasted up to 72 h after a single administration of A. The observation that cultured pituitary cells repeatedly exposed to A showed a similar blunting of LRF-induced LH elevation suggests that the decrease in pituitary responsiveness was not exclusively due to steroid feedback. Administration of T propionate to A-treated intact rats was unable to restore normal testicular weights and seminiferous tubule morphology, whereas in hypophysectomized rats, T propionate maintained qualitatively normal spermatogenesis even in the presence of A. These results coupled with the observation that high levels of hCG and PMS gonadotropin had effects similar to those of A on the tubular morphology of intact rats suggest the importance of pituitary secretion in mediating the deleterious effects of A on reproductive functions in the male rat.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 385303     DOI: 10.1210/endo-105-5-1191

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Protective effects of analogs of luteinizing hormone-releasing hormone against chemotherapy-induced testicular damage in rats.

Authors:  T Karashima; A Zalatnai; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 2.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

3.  Sensitivity of luteinizing hormone and gonadal steroid responses to single intranasal administration of an LHRH agonist (Hoe-766) in young normal adult men.

Authors:  N Faure; F Labrie; A Belanger; A Lemay; J P Raynaud; M Von der Ohe; A T Fazekas
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

4.  Direct inhibition of testicular function by gonadotropin-releasing hormone: mediation by specific gonadotropin-releasing hormone receptors in interstitial cells.

Authors:  R N Clayton; M Katikineni; V Chan; M L Dufau; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

5.  Kisspeptin-54 at high doses acutely induces testicular degeneration in adult male rats via central mechanisms.

Authors:  E L Thompson; V Amber; G W H Stamp; M Patterson; A E Curtis; J H Cooke; G F Appleby; W S Dhillo; M A Ghatei; S R Bloom; K G Murphy
Journal:  Br J Pharmacol       Date:  2009-02       Impact factor: 8.739

6.  Inhibition of growth of the transplantable rat chondrosarcoma by analogs of hypothalamic hormones.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

7.  Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.

Authors:  S R Ahmed; J Grant; S M Shalet; A Howell; S D Chowdhury; T Weatherson; N J Blacklock
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

8.  Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.

Authors:  B Warner; T J Worgul; J Drago; L Demers; M Dufau; D Max; R J Santen
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

9.  Dose-dependent response to an intratesticular injection of calcium chloride for induction of chemosterilization in adult albino rats.

Authors:  K Jana; P K Samanta; D Ghosh
Journal:  Vet Res Commun       Date:  2002-12       Impact factor: 2.459

10.  Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.